API‐ILs Ionic Adducts: Solubility and Surface Activity Properties—En Route to New Paradigm in Drug Development

Two novel, structurally different perfluoroalkyl ionic liquids with bicyclic guanidinium cation have been synthesized and applied as a surfactant component for selected active pharmaceutical ingredients (APIs). The addition of perfluoroalkyl ionic liquid to hydrophobic APIs significantly improves their solubility. One of the key and characteristic properties of guanidine derivatives is their strong ability to chemisorb protons (proton affinity). This property enables them to form stable ionic-type aggregates (adducts) with selected hydrophobic APIs containing carboxylic groups. Therefore, these new compounds are, in fact, API-IL ionic adducts formed as hydrogen bond donor-acceptor systems. The obtained adducts are characterized by significantly better solubility than the initial APIs. The presence of perfluoroalkyl chains with unique surface-active properties enables to obtain a solubility of new adducts to reach level sufficient for typical ophthalmic preparations. (e.g., eye drops or lens care). The ionic API-IL adducts obtained in the described studies can be considered as examples of a new class of active derivatives with pharmaceutical potential.

Authors

Institutions

Publication Details

Journal
ChemMedChem
Published
2025-10-07
DOI
https://doi.org/10.1002/cmdc.202500404
Primary Topic
Surfactants and Colloidal Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

API‐ILs Ionic Adducts: Solubility and Surface Activity Properties—En Route to New Paradigm in Drug Development

Marcin Muszyński, Marian M. Zgoda, Janusz Nowicki, Michał Kołodziejczyk et al.
ChemMedChem
Surfactants and Colloidal Systems
article

API‐ILs Ionic Adducts: Solubility and Surface Activity Properties—En Route to New Paradigm in Drug Development

Marcin Muszyński, Marian M. Zgoda, Janusz Nowicki, Michał Kołodziejczyk, Jyri‐Pekka Mikkola
article en

Abstract

Two novel, structurally different perfluoroalkyl ionic liquids with bicyclic guanidinium cation have been synthesized and applied as a surfactant component for selected active pharmaceutical ingredients (APIs). The addition of perfluoroalkyl ionic liquid to hydrophobic APIs significantly improves their solubility. One of the key and characteristic properties of guanidine derivatives is their strong ability to chemisorb protons (proton affinity). This property enables them to form stable ionic-type aggregates (adducts) with selected hydrophobic APIs containing carboxylic groups. Therefore, these new compounds are, in fact, API-IL ionic adducts formed as hydrogen bond donor-acceptor systems. The obtained adducts are characterized by significantly better solubility than the initial APIs. The presence of perfluoroalkyl chains with unique surface-active properties enables to obtain a solubility of new adducts to reach level sufficient for typical ophthalmic preparations. (e.g., eye drops or lens care). The ionic API-IL adducts obtained in the described studies can be considered as examples of a new class of active derivatives with pharmaceutical potential.

ChemMedChemVol. 20(21)
Silesian University of Technology (PL), Medical University of Lodz (PL), Łukasiewicz Research Network - Institute of Heavy Organic Synthesis "Blachownia" (PL), Umeå University (SE)
Openalex Percentile: Top 79%
Surfactants and Colloidal Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

API‐ILs Ionic Adducts: Solubility and Surface Activity Properties—En Route to New Paradigm in Drug Development — Marcin Muszyński, Marian M. Zgoda, et al. · ChemMedChem (2025) | TGRS Research Map | TGRS